Sexual Performance & Libido

Diminished hormone levels impact male and female sexual drives and performance. Studies also reveal that hyperthyroidism and hypothyroidism negatively affect testosterone metabolism. This section offers various observations with hormonal therapy, exposing pros and cons. Review current research and medical articles on sexual performance and libido to help restore a patient’s quality of life.


Prostate Cancer and the Testosterone ‘Myth’.pdf

In this interview, Abraham Morgentaler, M.D. concludes his comments saying that “testosterone treatment can be enormously helpful for many men. Attitudes are shifting with regard to its relationship to prostate cancer.” He references his article on the subject that appeared in European Urology in 2006.
(2007, February 25). Prostate cancer and the testosterone ‘myth’ [Electronic version]. Vitasearch.com. (PDF).

Hormones and Sexuality During Transition to Menopause.pdf

This study confirms the observation that sexual dysfunction increases over the menopausal transition. Several factors associated with sexual dysfunction include low DHEAS, absence of a sexual partner, anxiety, and children under the age of 18 living at home.
Gracia, C.R., Freeman, E.W., Sammel, M.D., Lin, H. & Mogul, M. (2007). Hormones and sexuality during transition to menopause [Electronic version]. Obstetrics and Gynecology, 109(4), 831-840. Retrieved May 31, 2007.

Fountain of Youth Overflows with Hormones.pdf

According to this article, as baby boomers age, the fight against aging is being combated by increased exercise, better eating habits and the use of testosterone and other hormone replenishments.
Stetz, M. (2007, March 5). Fountain of youth overflows with hormones [Electronic version]. The San Diego Union-Tribune. Retrieved May 2, 2007.

Male Menopause.pdf

According to this article, women may not be the only ones who suffer the effects of changing hormones. Some doctors are noticing that their male patients are reporting some of the same symptoms that women experience in menopause.
(2006, April 5). Male menopause [Electronic version]. Cleveland Clinic Website. Retrieved May 2, 2007.

Male Menopause Out of the Closet.pdf

According to this article, as men age, their testosterone levels gradually decline and some men go through what is now called male menopause. But many never get diagnosed or treated because until now male menopause has been in the closet.
Schieszer, J. (2006, October 1). Male menopause out of the closet [Electronic version]. MSNBC.com Website. Retrieved May 2, 2007.

Don’t Call it Male Menopause.pdf

As men start to age, their bodies also start to undergo major changes. They don't get hot flashes, but they do experience hormonal, physiological and chemical shifts that can affect many aspects of their lives. This article suggests that you can call it aging; just don't call it male menopause.
Yara, S. (2006, September 28). Don’t call it male menopause [Electronic version]. Forbes.com Website. Retrieved May 2, 2007.

Pharmacokinetics of Two Novel Bicalutamide Formulations in Healthy Male Volunteers.pdf

In this study, the oral bioavailability of two investigational formulations of bicalutamide was compared with the current clinical formulation. Clinically insignificant increases in circulating luteinizing hormone and testosterone plasma concentrations were observed for both R-bicalutamide/HP55S and R-/S-bicalutamide/HP55S compared with bicalutamide 150 mg. Both new bicalutamide formulations were well tolerated.
Cantarini, M., Fuhr, R. & Morris T. (2006). Pharmacokinetics of two novel bicalutamide formulations in healthy male volunteers [Electronic version]. Pharmacology, 77(4), 171-178. Epub July 17, 2006. Retrieved November 27, 2006.

Testosterone: Estradiol Ratio Changes Associated with Long-Term Tadalafil Administration: A Pilot Study.pdf

According to this study, sustained improvement in sexual function after 12 months of tadalafil administration is associated with increased T:E ratio mainly related to reduction of E levels. The authors hypothesize that androgen-estrogen cross-talk and possible inhibition of aromatase activity during chronic exposure to tadalafil might have a role in the regulation of erectile function.
Greco, E.A., Pili, M., Bruzziches, R., Corona, G., Spera, G. & Aversa, A. (2006). Testosterone:estradiol ratio changes associated with long-term tadalafil administration: a pilot study [Electronic version]. The Journal of Sexual Medicine, 3(4), 716-722. Retrieved November 27, 2006.

The Age Related Decrease in Testosterone is Significantly Exacerbated in Obese Men with the Metabolic Syndrome. What are the Implications for the Relatively High Incidence of Erectile Dysfunction Observed in These Men?.pdf

This study demonstrated that aging men with obesity and the metabolic syndrome have a significant decrease in total serum testosterone levels compared to aging, metabolically healthy men. These data suggest that the well established association between erectile dysfunction and pre-diabetes/diabetes (particularly in obese pre-diabetic/diabetic patients) may involve a hormonal component.
Kaplan, S.A., Meehan, A.G. & Shah, A. (2006). The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? [Electronic version]. The Journal of Urology, 176(4 Pt. 1), 1524-1527, discussion 1527-1528. Retrieved November 27, 2006.

Prevalence of Hypogonadism in Males Aged at Least 45 Years: The HIM study.pdf

According to this study, based on TT concentration, the prevalence of hypogonadism in men reporting to primary care offices was estimated to be 38.7%. The medical conditions that occurred significantly more frequently among hypogonadal men than eugonadal men included increased BMI, hypertension, hyperlipidaemia, diabetes, and asthma or COPD. As men age, they are susceptible to conditions that share many of the same symptoms similar to hypogonadism. The presence of these conditions may, in effect, mask underlying hypogonadism and negatively impact quality of life.
Mulligan, T., Frick, M.F., Zuraw, Q.C., Stemhagen, A. & McWhirter, C. (2006). Prevalence of hypogonadism in males aged at least 45 years: the HIM study [Electronic version]. International Journal of Clinical Practice, 60(7), 762-769. Retrieved November 27, 2006.

Hormone Profiles After Intramuscular Injection of Testosterone Enanthate in Patients with Hypogonadism.pdf

To examine hormone levels after androgen replacement therapy (ART) in Japanese male patients with hypogonadism, nine Japanese male patients with hypogonadism (serum total testosterone (tT) or free testosterone (fT) levels of < or = 2.7 ng/mL or < or = 10 pg/mL, respectively; average age, 59 years) were enrolled.
Nakazawa, R., Baba, K., Nakano, M., Katabami, T., Saito, N., Takahashi, T., et al. (2006). Hormone profiles after intramuscular injection of testosterone enanthate in patients with hypogonadism  [Electronic version]. Endocrine Journal, 53(3), 305-310. Epub May 19, 2006.

Management of Andropause: The Male Menopause.pdf

According to this article, andropause is a syndrome of physical, sexual, and psychological symptoms in aging men due to a gradual decline in serum testosterone levels. Its symptoms are more prominent in the presence of concomitant medical disorders. Testosterone replacement therapy relieves these symptoms along with improvement in bone and muscle mass, sexual function, and quality of life.
Tunuguntla, H.S.G.R. (2005, November), Management of andropause: the male menopause [Electronic version]. Clinical Geriatrics, 13(11), 27-34. Retrieved May 2, 2007.

Experts Consider HT for Younger Women.pdf

Questions still persist after the release of the July 2002 Women’s Health Initiative findings regarding hormone therapy.  Researchers have been looking at the data to see if certain changes in dosage or initiation age could still provide benefits to women.
Elliott, V.S., (2005, February 28). Experts consider HT for younger women [Electronic version]. American Medical News, pp. 19-20.  Retrieved April 28, 2005.

Testosterone Supplementation in Hypogonadal Men: Our Personal Experience.pdf

According to this study, although compliance to testosterone treatment has not been equal in the time in all the subjects, undesirable effects are not highlighted. All the patients have reported complete or partial recovery of physical efficiency and improvement of sexual life, evaluated by means of IIEF scale and ADAM-AMS questionnaires. The replacement pharmacological treatment with testosterone improves the physical and sexual performance of the adult patient affected by symptomatic hypogonadism.
Giuberti, A., Picozzi, S.C., Mazza, L., Casu, M., Vigano, P., Manganini, V., et al. (2005). Testosterone supplementation in hypogonadal men: our personal experience [Electronic version]. Archivio Italiano di Urologia, Andrologia, 77(4), 191-193. Retrieved November 13, 2006.

Male Hormones Could Help Slow Aging in Men, WU Doctor Says.pdf

According to this article, the natural medical response to decreasing testosterone in men is to want to replenish low hormone levels. Yet no large-scale study has done for men what the massive Women's Health Initiative did for women: Investigate the effects of replacing important sex hormones in the aging. But as demographic shifts bring an increasingly older population, male hormone replacement therapy, or HRT, is becoming a priority.
Kean, S. (2005, August 2). Male hormones could help slow aging in men, WU doctor says [Electronic version]. St. Louis Post-Dispatch. Retrieved October 20, 2005.

Treating Low Testosterone in Older Men Remains Controversial. Treating Hypogonadism in Older Men May Reduce Mortality, but Long-Term Data are Limited.pdf

Adrian Dobs, MD, professor of endocrinology at the Johns Hopkins University School of Medicine, spoke about low testosterone at the 87th Annual Meeting of the Endocrine Society.  Dobs said data from the Baltimore Longitudinal Study of Aging demonstrated that as many as 50% of men between the ages of 70 and 79 may have hypogonadism.
Lewis, J. (2005). Treating low testosterone in older men remains controversial. Treating hypogonadism in older men may reduce mortality, but long-term data are limited [Electronic version]. Endocrine Today, 3(8), 19. (PDF)

Endogenous Sex Hormones and Metabolic Syndrome in Aging Men.pdf

This study concluded that higher testosterone and SHBG levels in aging males are independently associated with a higher insulin sensitivity and a reduced risk of the metabolic syndrome, independent of insulin levels and body composition measurements, suggesting that these hormones may protect against the development of metabolic syndrome.
Muller, M., Grobbee, D.E., den Tonkelaar, I., Lamberts, S.W. & van der Schouw, Y.T. (2005). Endogenous sex hormones and metabolic syndrome in aging men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 90(5), 2618-2623. Epub 2005, February 1. Retrieved September 19, 2005.

Hormone Replacement, the Male Version.pdf

According to this article, a growing number of men in the United States are now taking testosterone to reverse the gradual, age-related decline of the hormone, or so-called andropause. By some estimates, the number of testosterone prescriptions in the United States has tripled in recent years, and total sales now come to about $400 million a year. That’s not much compared with the $12.5 billion spent on cholesterol-lowering statins, but the upward trend is still impressive.
(2004, May). Hormone replacement, the male version [Electronic version]. Harvard Health Letter. Retrieved May 2, 2007.

Predictors of Decreased Libido in Women During the Late Reproductive Years.pdf

This study concluded that decreased libido in the late reproductive years is associated with a pronounced fluctuation in total testosterone over time. Other independent risk factors for decreased libido include vaginal dryness, depression, and living with children. Sexual dysfunction is a complex disorder, related to physiological and psychosocial factors, requiring further investigation.
Gracia, C.R., Sammel, M.D., Freeman, E.W., Liu, L., Hollander, L. & Nelson, D.B. (2004). Predictors of decreased libido in women during the late reproductive years [Electronic version]. Menopause, 11(2), 144-150. Retrieved May 8, 2007.

Study: Half of Internet Viagra is Fake - Analyzed Samples Contain Less of Active Drug, Other Ingredients.pdf

As many as half of the Viagra anti-impotence pills sold on the Internet could be counterfeit.  With impotence, or erectile dysfunction (ED), affecting about 152 million men worldwide, there is a huge market for the treatment.
(2004, September 28). Study: half of internet viagra is fake - Analyzed samples contain less of active drug, other ingredients [Electronic version]. Reuter’s.  Retrieved April 14, 2005.

Androgen Replacement in Men with Hypogonadism and Erectile Dysfunction.pdf

This paper concludes that therapy should be individualized, considered carefully, and closely monitored because of potential risks, especially in older men.
Albrecht-Betancourt, M., Hijazi, R.A. & Cunningham, G.R. (2004). Androgen replacement in men with hypogonadism and erectile dysfunction [Electronic version]. Endocrine, 23(2-3), 143-148. Retrieved November 21, 2005.

One Year Follow-up Study of the Association Between Chemical Castration, Sex Hormones, Beta-Amyloid, Memory and Depression in Men.pdf

The results of this naturalistic study indicate that chemical castration is associated with a significant rise in the plasma levels of Abeta and, clinically, with increased depression and anxiety scores. The discontinuation of treatment is associated with better cognitive performance, most noticeably of verbal memory. The performance of subjects on the WL test was negatively correlated with plasma levels of Abeta, but the clinical significance of this finding remains to be determined.
Almeida, O.P., Waterreus, A., Spry, N., Flicker, L. & Martins, R.N. (2004). One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men [Electronic version]. Psychoneuroendocrinology, 29(8), 1071-1081. Retrieved November 18, 2005.

Safety and Adverse Effects of Androgens: How to Counsel Patients.pdf

In short-term clinical trials of androgen replacement in women, several benefits have been shown, including improved libido, bone mineral density and body composition.  While androgen therapy for women is relatively new, it is receiving more attention.
Basaria, S. & Dobs, A.S. (2004). Safety and adverse effects of androgens: how to counsel patients [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S25-32. Retrieved May 18, 2005.

Formulations and Use of Androgens in Women.pdf

The use of androgen therapy for postmenopausal women is discussed in this article.  It suggests that the goal of androgen treatment should be to achieve normal premenopausal levels of testosterone, thus limiting adverse effects and adverse experiences. 
Chu, M.C. & Lobo, R.A. (2004). Formulations and use of androgens in women. [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S3-7. Retrieved May 18, 2005.

Low Testosterone Common in Type 2 Diabetes Study: 1 in 3 Diabetic Men May Suffer Low Sex Hormone Levels.pdf

A third of men with type 2 diabetes have low testosterone levels, a new study suggests.  Testosterone helps men reduce body fat and improves the way their bodies handle insulin. So low testosterone levels may have serious consequences for men with diabetes, suggests Sandeep Dhindsa, MD, of State University of New York at Buffalo.
DeNoon, D. (2004, December 1). Low testosterone common in type 2 diabetes study: 1 in 3 diabetic men may suffer low sex hormone levels. WebMD Health. Retrieved December 12, 2006.

Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes.pdf

Type 2 diabetes is associated with lower total testosterone levels in cross-sectional studies. However, it is not known whether the defect is primary or secondary.  This article concludes that hypogonadotropic hypogonadism occurs commonly in type 2 diabetes.
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A. & Dandona, P. (2004). Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes [Electronic version].  Journal of Clinical Endocrinology and Metabolism, 89(11), 5462-5468. Retrieved January 19, 2005.

Androgen Replacement After Curative Radical Prostatectomy for Prostate Cancer in Hypogonadal Men.pdf

According to this study, based on the clinical experience with this small group of men, and indirect evidence of the safety of this approach from epidemiological and clinical data, further cautious use of testosterone in a carefully selected population seems warranted.
Kaufman, J.M. & Graydon, R.J. (2004). Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men [Electronic version]. The Journal of Urology, 172(3), 920-922. Retrieved November 21, 2005.

Review of the Book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.pdf

Review by Amazon.com of Suzanne Somers’ book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.
Lightner, J. (2004). [Review of the book The sexy years: Discover the hormone connection: the secret to fabulous sex, great health, and vitality, for women and men]. Retrieved September 10, 2004.

Hot Flashes and Androgens: A Biological Rationale for Clinical Practice.pdf

This article discusses the important role androgens play in the treatment of hot flashes.  It also emphasizes the need to individualize treatment for menopausal women.
Notelovitz, M. (2004). Hot flashes and androgens: a biological rationale for clinical practice [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S8-13. Retrieved May 18, 2005.

Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring.pdf

According to this study, hypogonadism affects an estimated 2 million to 4 million men in the United States; its prevalence increases with age. However, it has been estimated that only 5 percent of affected men currently receive treatment. Recent interest in testosterone therapy has been fueled not only by increased medical awareness of the effects of hypogonadism, but also by media attention regarding hormone-replacement therapy in both men and women, the marketing of new topical testosterone formulations, and the desire of "baby boomers" to maintain vigor and health into their more mature years.
Rhoden, E.L. & Morgentaler, A. (2004). Risks of testosterone-replacement therapy and recommendations for monitoring [Electronic version]. The New England Journal of Medicine, 350(5), 482-492. Retrieved September 27, 2005.

The Role of Androgens in Female Sexual Dysfunction.pdf

Although there are no FDA-approved androgen therapies at this time, increased attention is being paid to low androgen concentrations in the treatment of female sexual dysfunction (FSD).
Shifren, J.L. (2004). The role of androgens in female sexual dysfunction [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S19-24. Retrieved May 18, 2005.

Testosterone Treatment Improves Body Composition and Sexual Function in Men with COPD, in a 6-Month Randomized Controlled Trial.pdf

This article concludes that administration of a low-dose testosterone to men with COPD for 26 weeks was associated with improvement of body composition, better erectile function and sexual quality of life. Furthermore, there were no clinical or biochemical side effects.
Svartberg, J., Aasebo, U., Hjalmarsen, A., Sundsfjord, J. & Jorde, R. (2004). Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial [Electronic version]. Respiratory Medicine, 98(9), pp. 906 - 913. Retrieved September 10, 2004.

Does Testosterone Boost an Actor's Oscar Odds?.pdf

Testosterone surges may be one of the factors that separate Oscar-winners like Jack Nicholson and Al Pacino from aspiring actors whose careers never get off the ground, new study findings suggest.
Stenson, J. (2003, March 21). Does testosterone boost an actor's Oscar odds? [Electronic version]. Reuters Health. Retrieved October 31, 2005.

Can Growth Hormone Prevent Aging?.pdf

This article cites the article by Rudman et al. that appeared in the Journal in 1990 that reported the effect on body composition of administering human growth hormone for six months to 12 older men. This article incited a proliferation of "antiaging" clinics and lay publications, such as "Grow Young with HGH," extolling the benefits of growth hormone in reversing or preventing aging.
Vance, M.L. (2003). Can growth hormone prevent aging? [Electronic version]. The New England Journal of Medicine, 348(9), 779-780. Retrieved October 31, 2005.

Male Menopause & Chronic Fatigue Syndrome.pdf

This article says that it might come as a shock to some, but men can suffer from a form of menopause similar to what women endure. In fact this malady, sometimes called male menopause, shares a number of Chronic Fatigue Syndrome (CFS) symptoms.
Addington, J.W. (2002, January 2). Male menopause & chronic fatigue syndrome [Electronic version]. ImmuneSupport.com Website. Retrieved October 31, 2005.

Single and Combined Effects of Growth Hormone and Testosterone Administration on Measures of Body Composition, Physical Performance, Mood, Sexual Function, Bone Turnover, and Muscle Gene Expression in Healthy Older Men.pdf

This study examined the effects of GH and/or testosterone (T) administration on body composition, performance, mood, sexual function, bone turnover, and muscle-gene expression in healthy older men.  It concluded that 1 month of GH and/or T administration improves certain measures of balance and physical performance in older men and increases muscle IGF-I gene expression.
Brill, K.T., Weltman, A.L., Gentili, A., Patrie, J.T., Fryburg, D.A., Hanks, J.B., et al. (2002). Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 87(12), 5649-5657. Retrieved January 4, 2006.

The Effects of Recombinant Human Growth Hormone on the Metabolism of Branch Chain Amino Acid in Severely Burned Patients.pdf

Fifty severely-burned patients were enrolled in this study, the aim of which was to explore the effects of recombinant human growth hormone (rhGH) on the metabolism of branch chain amino acid when applied postoperatively.
Chai, J., Hao, D., Wu, Y., Shen, C. & Sheng, Z. (2002). [The effects of recombinant human growth hormone on the metabolism of branch chain amino acid in severely burned patients] [Article in Chinese] [Electronic version]. Zhonghua Shao Shang Za Zhi [Chinese Journal of Burns], 18(4), 229-31. Retrieved May 18, 2005.

The Effects of Tibolone on Mood and Libido.pdf

According to this paper, published studies indicate beneficial effects of tibolone on both libido and mood, which otherwise significantly compromise physical, psychological, and social well-being. Hence, tibolone provides another option for menopausal women experiencing loss of libido as part of their symptomatology or who have persistent low libido despite adequate estrogen/progestin replacement therapy.
Davis, S.R. (2002). The effects of tibolone on mood and libido [Electronic version]. Menopause, 9(3), 162-170. Retrieved October 3, 2005.

What are "Normal" Testosterone Levels for Women?.pdf

In this Letter to the Editor, the authors conclude that the role of androgens in women is becoming increasingly more recognized and established. Certainly, the use of androgens, particularly testosterone, has been shown to influence life aspects, such as mood, women’s general well being and restoration of sexual desire. However, there is limited data establishing normal androgen values for women of differing ages, to enable us to define those with "androgen deficiency." They say it is, therefore, necessary to highlight the incongruencies and short-comings of the paper by Laughlin et al. (Laughlin G, Barrett-Connor E, Kritz-Silverstein D, Von Muhlen D. 2000 Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernado Study. J Clin Endocrinol Metab. 85:645–651), and the need for larger prospective studies to establish the variations in testosterone levels in women with age.
Davis, S. & Tran, J. (2001). What are "normal" testosterone levels for women? [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 86(4), 1842-1844. Retrieved October 3, 2005.

Hormonal Erectile Dysfunction. Evaluation and Management.pdf

This study showed that persistent low testosterone levels may have significant detrimental effects in other organ systems; therefore, a timely diagnosis of androgen deficiency and appropriate treatment may have significant effects outside the narrow field of sexual performance.
Morales, A. & Heaton, J.P. (2001). Hormonal erectile dysfunction. Evaluation and management [Electronic version]. The Urologic Clinics of North America, 28(2), 279-288. Retrieved October 3, 2005.

Personal Business; Trying to Roll Back the Biological Clock, for a Price.pdf

This article, written soon after September 11th, says that Americans have been re-evaluating their priorities since the attacks, and for some people that means paying closer attention to their health. There has even been a rise in interest in so-called anti-aging clinics.  It discusses several clinics, including Cenegenics.
Siwolop, S. (2001, October 21). Personal business; trying to roll back the biological clock, for a price [Electronic version]. The New York Times. Retrieved October 31, 2005.

Androgen Replacement Therapy in the Aging Male--A Critical Evaluation.pdf

This article concludes that aging is unavoidable and physiologic, but the large interindividual disparity in the pace of development and progression of signs and symptoms of aging, suggests that the development of this symptomatology can be delayed and that a high quality of life can be maintained until a very advanced age, in other words that it is possible to add life to years. Being aware of these possibilities, more and more elderly men (and women) will seek medical help to achieve these goals.
Vermeulenn, A. (2001). Androgen replacement therapy in the aging male--a critical evaluation [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 86(6), 2380-2390. Retrieved October 3, 2005.

Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men. Testosterone Gel Study Group.pdf

This study concluded that T gel replacement improved sexual function and mood, increased lean mass and muscle strength (principally in the legs), and decreased fat mass in hypogonadal men with less skin irritation and discontinuation compared with the recommended dose of the permeation-enhanced T patch.
Wang, C., Swedloff, R.S., Iranmanesh, A., Dobs, A., Snyder, P.J., Cunningham, G., et al. (2000). Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone gel study group [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 85(8), 2839-2853. Retrieved July 19, 2003.

Sexuality Among Older Women.pdf

According to this article, in addition to hormonal changes with aging, disease and associated medications may also negatively affect sexuality. Determining the impact of medications, both alone and in combination with others, on quality of life must be considered when providing comprehensive care for elderly patients.
Gelfand, M.M. (2000). Sexuality among older women [Electronic version]. Journal of Women’s Health and Gender-Based Medicine, 9(Suppl. 1), S15-20. Retrieved October 3, 2005.

Testosterone Supplementation for Erectile Dysfunction: Results of a Meta-Analysis.pdf

In this study, the meta-analysis of the usefulness of androgen replacement therapy for erectile dysfunction indicates that the response rate for a primary etiology was improved over that for a secondary etiology, transdermal testosterone therapy was more effective than intramuscular or oral treatment, and intramuscular and oral treatments were equivalent. In addition, there was a statistically significant difference in favor of testosterone over placebo, implying a role for supplementation in select groups.
Jain, P., Rademaker, A.W. & McVary, K.T. (2000). Testosterone supplementation for erectile dysfunction: results of a meta-analysis [Electronic version]. The Journal of Urology, 164(2), 371-375. Retrieved October 3, 2005.

Testosterone Therapy in Men: An Update.pdf

This article discusses that because testosterone levels decline with age, and aging is accompanied by body changes including loss of muscle and increases in fat, there is great interest in the potential benefits of testosterone administration in elderly men.
Katznelson, L. (2000, Winter). Testosterone therapy in men: an update [Electronic version]. MGH Neuroendocrine Clinical Center Newsletter Bulletin, 6(2). Retrieved September 14, 2005.

Testosterone Replacement and the Physiologic Aspects of Aging in Men.pdf

The focus of the clinical investigations described here is to determine whether testosterone deficiency is a physiologic cause of the aging process and whether testosterone replacement might prevent or ameliorate a decline in quality of life associated with age-related decline in physical and psychological functioning.
Morley, J.E. (2000). Testosterone replacement and the physiologic aspects of aging in men [Electronic version]. Mayo Clinic Proceedings, 75 Suppl., S83-7. Retrieved October 3, 2005.

Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency.pdf

In a double-blind study, 24 women with adrenal insufficiency received in random order 50 mg of dehydroepiandrosterone orally each morning for four months and placebo daily for four months, with a one-month washout period. The study concluded that dehydroepiandrosterone improves well-being and sexuality in women with adrenal insufficiency.
Arlt, W., Callies, F., van Vlijmen, J.C., Koehler, I., Reincke, M., et al. (1999). Dehydroepiandrosterone replacement in women with adrenal insufficiency [Electronic version]. The New England Journal of Medicine, 341(14), 1013-1020. Retrieved September 14, 2005.

Risks Versus Benefits of Testosterone Therapy in Elderly Men.pdf

This review discusses the pros and cons of testosterone replacement in hypogonadal elderly men and attempts to answer some of the unanswered questions. Furthermore, emphasis is made on the regular follow-up of these patients to prevent the development of therapy-related complications.
Basaria, S. & Dobs, A.S. (1999). Risks versus benefits of testosterone therapy in elderly men [Electronic version]. Drugs & Aging, 15(2), 131-142. Retrieved September 14, 2005.

Anabolic Interventions for Age-Associated Sarcopenis.pdf

This commentary concludes that the body composition changes in old age are multifactorial and may be related to the concomitant changes in hormone production, protein turnover, and disuse atrophy. The evidence to support the use of testosterone or GH supplementation in age-related sarcopenia is only beginning to be presented.
Bross, R., Javanbakht, M. & Bhasin, S. (1999). Anabolic interventions for age-associated sarcopenis [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 84(10), 3420-30. Retrieved October 3, 2005.

Down-Regulation Models and Modeling of Testosterone Production Induced by Recombinant Human Choriogonadotropin.pdf

Presented is a modeling study to provide a possible explanation for the observations that increased exposure to rhCG induces higher and then lower testosterone concentrations and that marked rebound effects are observed at the end of repeated administration of rhCG. The modeling results indicate that when rhCG concentration increases, the testosterone production rate increases to 45 times the baseline value. However, at an rhCG concentration of more than about 30 IU/liter, the production rate decreases. Simulations showed that both dose and dosing interval profoundly influence testosterone response to rhCG.
Gries, J.M., Munafo, A., Porchet, H.C. & Verotta, D. (1999). Down-regulation models and modeling of testosterone production induced by recombinant human choriogonadotropin [Electronic version]. The Journal of Pharmacology and Experimental Therapeutics, 289(1), 371-377. Retrieved October 3, 2005.

Psychosexual Effects of Menopause: Role of Androgens.pdf

The effects of androgens in the brain are mediated through androgen-specific receptors and by the aromatization of testosterone to estradiol. Alterations in the circulating levels of androgens play an important role in psychologic and sexual changes that occur after menopause.
Sarrel, P.M. (1999). Psychosexual effects of menopause: role of androgens [Electronic version]. American Journal of Obstetrics and Gynecology, 180(3 Pt. 2), S319-24. Retrieved October 3, 2005.

Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review.pdf

The importance of GH throughout adult life is now unequivocally accepted.  GH deficiency is recognized to result in alterations in body composition, physical performance, psychological well-being, and substrate metabolism.  Many of these alterations can be improved or corrected with GH replacement.  The prospect of GH replacement becoming routine, however, does raise a number of issues.
Carroll, P.V., Christ, E.R., Bengtsson, B.A., Carlsson, L., Christiansen, J.S., et al.  (1998). Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 83(2), 382-395. Retrieved May 17, 2005.

Effect of Exogenous Testosterone on Prostate Volume, Serum and Semen Prostate Specific Antigen Levels in Healthy Young Men.pdf

According to this study, despite significant elevations in serum total and free testosterone, healthy young men do not demonstrate increased serum or semen PSA levels, or increased prostate volume in response to exogenous testosterone injections.
Cooper, C.S., Perry, P.J., Sparks, A.E., MacIndoe, J.H., Yates, W.R. & Williams, R.D. (1998). Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men [Electronic version]. The Journal of Urology, 159(2), 441-443. Retrieved October 3, 2005.

The Use of a Sensitive Equilibrium Dialysis Method for the Measurement of Free Testosterone Levels in Healthy, Cycling Women and in Human Immunodeficiency Virus-Infected Women.pdf

The objectives of this study were to develop sensitive assays for the measurement of the low total and free testosterone levels in women to define the range for these hormones during the normal menstrual cycle and assess the total and free testosterone levels in HIV-infected women.
Sinha-Hikim, I., Arver, S., Beall, G., Shen, R., Guerrero, M., Sattler, F., et al. (1998). The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 83(4), 1312-1318. Retrieved October 3, 2005.

Decreased Psychological Well-Being in Adult Patients with Growth Hormone Deficiency.pdf

This study concluded that adult patients with GH deficiency have a decreased psychological well-being in terms of energy, social isolation and emotional reaction and a disturbed sex life compared with normals. Furthermore, there is a tendency to a higher frequency of early retirement.
Rosen, T., Wiren, L., Wilhelmsen, L., Wiklund, I. & Bengtsson, B.A. (1994). Decreased psychological well-being in adult patients with growth hormone deficiency [Electronic version]. Clinical Endocrinology (Oxford), 40(1), 111-116. Retrieved July 25, 2003.

A Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Conjugated Estrogens on Skin Thickness.pdf

This twelve-month study examines the possible increase in skin thickness in postmenopausal women as a result of being treated with conjugated estrogens.  The results of the study may be beneficial to women who are looking for information regarding the benefits of estrogen replacement therapy.
Maheux, R., Naud, F., Rioux, M., Grenier, R., Lemay, A., Guy, J. & Langevin, M. (1994). A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness [Electronic version]. American Journal of Obstetrics and Gynecology, 170(2), 642-649. Retrieved May 18, 2005.

Effects of Androgen Treatment in Impotent Men with Normal and Low Levels of Free Testosterone.pdf

The results of this study suggest the presence of a minimum serum fT threshold, lying near the lower normal range, which determines the male sexual function. Moreover, serum fT levels were a more sensitive index than tT for identifying impotent men who can be successfully treated with androgens.
Carani, C., Zini, D., Baldini, A., Della Casa, L., Ghizzani, A. & Marrama, P. (1990). Effects of androgen treatment in impotent men with normal and low levels of free testosterone [Electronic version]. Archives of Sexual Behavior, 19(3), 223-234. Retrieved October 3, 2005.

Hormonal Responses to a Potent Gonadotropin Hormone-Releasing Hormone Antagonist in Normal Elderly Men.pdf

The results of this study demonstrate that the response to Nal-Glu in healthy elderly men is similar to that in younger men, and extended administration of Nal-Glu in elderly men effectively suppresses gonadal and pituitary function. These results suggest that the role of GnRH antagonists in the effective treatment of androgen-dependent disease in the aging male needs to be explored further.
Tenover, J.S., Dahl, K.D., Vale, W.W., Rivier, J.E. & Bremner, W.J. (1990). Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 71(4), 881-888. Retrieved October 3, 2005.

Influence of Phlebotomy Treatment on Abnormal Hypothalamic-Pituitary Function in Genetic Hemochromatosis.pdf

To test the hypothesis that deficiencies in hypothalamic-pituitary function in genetic hemochromatosis result from cellular injury by iron deposits, this study conducted provocative tests in 11 men with genetic hemochromatosis before and after iron depletion by serial phlebotomy and in 10 control subjects. The study concluded that abnormal hypothalamic-pituitary function in genetic hemochromatosis is not substantially improved by iron-depletion therapy.
Lufkin, E.G., Baldus, W.P., Bergstralh, E.J. & Kao, P.C. (1987). Influence of phlebotomy treatment on abnormal hypothalamic-pituitary function in genetic hemochromatosis [Electronic version]. Mayo Clinic Proceedings, 62(6), 473-479. Retrieved October 26, 2005.

Hypogonadotropic Hypogonadism in Hemochromatosis: Recovery of Reproductive Function After Iron Depletion.pdf

This study examined the effect of iron depletion on reproductive function in a 37-yr-old man with hypogonadotropic hypogonadism due to idiopathic hemochromatosis. It was concluded that phlebotomy alone may be adequate treatment for hypogonadotropic hypogonadism in men with hemochromatosis.
Siemons, L.J. & Mahler, C.H. (1987). Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 65(3), 585-587. Retrieved October 26, 2005.

Hypogonadism in Hemochromatosis: Reversal with Iron Depletion.pdf

The findings of this study indicate that in some men with hereditary hemochromatosis and hypogonadism of either testicular or central origin, sexual function and sex hormone concentrations can be restored to normal after iron depletion therapy.
Kelly, T.M., Edwards, C.Q., Meikle, A.W. & Kushner, J.P. (1984). Hypogonadism in hemochromatosis: reversal with iron depletion [Electronic version]. Annals of Internal Medicine, 101(5), 629-632. Retrieved October 26, 2005.

Testosterone Therapy for Low Sexual Interest and Erectile Dysfunction in Men: A Controlled Study.pdf

The results of this study support previous findings from hypogonadal men that testosterone influences sexual interest but not erectile function, and indicate that increasing plasma testosterone can effect sexual interest even in men with pre-treatment testosterone levels within the normal range.
O'Carroll, R. & Bancroft, J. (1984). Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study [Electronic version]. The British Journal of Psychiatry, 145, 146-151. Retrieved October 3, 2005.

The Nature of Androgen Action on Male Sexuality: A Combined Laboratory-Self-Report Study on Hypogonadal Men.pdf

The data from this study and previous findings lead to the conclusion that the major androgen action on male sexuality involves libido factors (i.e. sexual motivation/interest). Though stimulus-bound erections elicited in the laboratory were not reduced in hypogonadal men, spontaneous (sleep or waking) erections were clearly testosterone dependent.
Kwan, M., Greenleaf, W.J., Mann, J., Crapo, L. & Davidson, J.M. (1983). The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 57(3), 557-562. Retrieved October 3, 2005.

Androgen Replacement with Oral Testosterone Undecanoate in Hypogonadal Men: A Double Blind Controlled Study.pdf

The effects of androgen withdrawal and replacement were investigated in six hypergonadotrophic and six hypogonadotrophic men with hypogonadism. There was a significant fall in sex hormone binding globulin, a rise in oestradiol and no significant change in gonadotrophin concentrations during T.U. administration.
Skakkebaek, N.E., Bancroft, J., Davidson, D.W. & Warner, P. (1981). Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study [Electronic version]. Clinical Endocrinology (Oxford), 14(1), 49-61. Retrieved October 3, 2005.

Gonadal Steroids: Effects on Excitability of Hippocampal Pyramidal Cells.pdf

Electrophysiological field potentials from hippocampal slices of rat brain show sex-linked differences in response to 1 X 10(-10)M concentrations of estradiol and testosterone added to the incubation medium. Slices from male rats show increased excitability to estradiol and not to testosterone. Slices from female rats are not affected by estradiol, but slices from female rats in diestrus show increased excitability in response to testosterone whereas slices from females in proestrus show decreased excitability. Teyler, T.J., Vardaris, R.M., Lewis, D. & Rawitch, A.B. (1980). Gonadal steroids: effects on excitability of hippocampal pyramidal cells [Electronic version]. Science, 209(4460), 1017-1018. Retrieved October 3, 2005.